Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes
Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes
Active, not recruiting · NCT02081326 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes | COVID-19, Coronaviridae Infections, Diabetes, Autoimmune, Infections, Nidovirales infectious disease, Nutritional and Metabolic Diseases, Orthocoronavirinae infectious disease, RNA Virus Infections, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, lung disorder, metabolic disease, pneumonia, respiratory system disorder, respiratory tract infectious disorder, type 1 diabetes mellitus, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 2 | 2026-04-13 | NCT02081326 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Massachusetts General Hospital | 758 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Immunobiology Labs CNY 149 | Charlestown | United States | 3 |